Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

510 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intravenous zoledronic acid in postmenopausal women with low bone mineral density.
Reid IR, Brown JP, Burckhardt P, Horowitz Z, Richardson P, Trechsel U, Widmer A, Devogelaer JP, Kaufman JM, Jaeger P, Body JJ, Brandi ML, Broell J, Di Micco R, Genazzani AR, Felsenberg D, Happ J, Hooper MJ, Ittner J, Leb G, Mallmin H, Murray T, Ortolani S, Rubinacci A, Saaf M, Samsioe G, Verbruggen L, Meunier PJ. Reid IR, et al. N Engl J Med. 2002 Feb 28;346(9):653-61. doi: 10.1056/NEJMoa011807. N Engl J Med. 2002. PMID: 11870242 Free article. Clinical Trial.
Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, Devogelaer JP, Hooper M, Su G, Zelenakas K, Pak J, Fashola T, Saidi Y, Eriksen EF, Reid IR. Hosking D, et al. Among authors: reid ir. J Bone Miner Res. 2007 Jan;22(1):142-8. doi: 10.1359/jbmr.061001. J Bone Miner Res. 2007. PMID: 17032148 Free article. Clinical Trial.
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR; HORIZON Pivotal Fracture Trial. Black DM, et al. Among authors: reid ir. N Engl J Med. 2007 May 3;356(18):1809-22. doi: 10.1056/NEJMoa067312. N Engl J Med. 2007. PMID: 17476007 Free article. Clinical Trial.
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.
Recker RR, Delmas PD, Halse J, Reid IR, Boonen S, García-Hernandez PA, Supronik J, Lewiecki EM, Ochoa L, Miller P, Hu H, Mesenbrink P, Hartl F, Gasser J, Eriksen EF. Recker RR, et al. Among authors: reid ir. J Bone Miner Res. 2008 Jan;23(1):6-16. doi: 10.1359/jbmr.070906. J Bone Miner Res. 2008. PMID: 17892374 Free article. Clinical Trial.
Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial.
Grbic JT, Landesberg R, Lin SQ, Mesenbrink P, Reid IR, Leung PC, Casas N, Recknor CP, Hua Y, Delmas PD, Eriksen EF; Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly Pivotal Fracture Trial Research Group. Grbic JT, et al. Among authors: reid ir. J Am Dent Assoc. 2008 Jan;139(1):32-40. doi: 10.14219/jada.archive.2008.0017. J Am Dent Assoc. 2008. PMID: 18167382 Clinical Trial.
Pathogenesis and management of Paget's disease of bone.
Ralston SH, Langston AL, Reid IR. Ralston SH, et al. Among authors: reid ir. Lancet. 2008 Jul 12;372(9633):155-163. doi: 10.1016/S0140-6736(08)61035-1. Lancet. 2008. PMID: 18620951 Review.
510 results